Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

Share Price is delayed by 15 minutes
Get Live Data
240.50    5.00 (2.12%)
Bid:
239.00
Ask:
240.00
Spread: 1.00 (0.418%)
Market Cap: £1.43b
MAB Live PriceLast checked at - London Stock Exchange

Intraday Mitchells & Butlers Share Chart

Holding(s) in Company

1 Oct 2015 09:45

RNS Number : 8790A
Mitchells & Butlers PLC
01 October 2015
 

1 October 2015

 

 

Mitchells & Butlers plc

 

 

TR-1: Notifications of Major Interests in Shares

 

1: Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Mitchells & Butlers PLC

 

2: Reason for notification (yes/no)

An acquisition or disposal of voting rights

yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

no

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

no

An event changing the breakdown of voting rights

no

Other (please specify):

 

no

 

3. Full name of person(s) subject to the notification

obligation:

Standard Life Investments (Holdings) Limited (Parent Company) -5.065% comprised of:

Standard Life Investments Limited - 5.065%

Ignis Investment Services Limited - 0%

4. Full name of shareholder(s) (if different from 3.):

 Vidacos Nominees\HSBC

5. Date of the transaction (and date on which the threshold

is crossed or reached):

29/09/2015

6. Date on which issuer notified:

30/09/2015

7. Threshold(s) that is/are crossed or reached:

5%

 

 

  

8: Notified Details
A: Voting rights attached to shares
Class/type of share If possible use ISIN code
GB00B1FP6H53
 
Situation previous to the triggering transaction
Number of shares
Number of voting rights
19,685,597
19,685,597
 
Resulting situation after the triggering transaction
Number of shares
Number of voting rights
Percentage ofvoting rights
Direct
Indirect
Direct
Indirect
20,893,535
15,749,591
5,143,944
3.818
1.247
 
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument
Expiration date
Exercise/ conversion period/date
No. of voting rights that may be acquired(if the instrument exercised/converted)
Percentage of voting rights
 
 
 
 
 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

20,893,535

5.065

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

Standard Life Investments (Holdings) Limited (Parent Company) -5.065% comprised of:

Standard Life Investments Limited - 5.065%

Ignis Investment Services Limited - 0%

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

 

GIOS@standardlife.comStandard Life Investments Ltd

15. Contact telephone number:

 

(0131) 245 6565

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMBBPTMBTMMTA
Date   Source Headline
29th May 202611:30 amRNSTotal Voting Rights
26th May 202612:00 pmRNSDirector/PDMR Shareholding
26th May 202611:30 amRNSDirector/PDMR Shareholding
21st May 20267:00 amRNSHALF YEAR RESULTS
14th May 20262:30 pmRNSNotice of Half Year Results
13th May 20263:30 pmRNSAdmission to Trading
30th Apr 20262:00 pmRNSTotal Voting Rights
27th Apr 20262:00 pmRNSDirector/PDMR Shareholding
24th Apr 20267:00 amRNSDirectorate change
31st Mar 20263:00 pmRNSTotal Voting Rights
30th Mar 20261:30 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:19 amRNSDirector/PDMR Shareholding
27th Feb 202611:50 amRNSTotal Voting Rights
13th Feb 20269:28 amRNSDirector/PDMR Shareholding
11th Feb 202611:00 amRNSDirectorate change
2nd Feb 20263:00 pmRNSDirector/PDMR Shareholding
30th Jan 20261:12 pmRNSTotal Voting Rights
29th Jan 20264:00 pmRNSResult of AGM
15th Jan 20267:00 amRNSFirst Quarter Trading Update
12th Jan 20261:30 pmRNSNotice of First Quarter Trading Update
5th Jan 20263:21 pmRNSDirector/PDMR Shareholding
2nd Jan 20269:27 amRNSTotal Voting Rights
18th Dec 202512:00 pmRNSAnnual Report 2025
18th Dec 202512:00 pmRNSAnnual Report 2025
15th Dec 202511:04 amRNSDirector/PDMR Shareholding
12th Dec 20251:49 pmRNSDirector/PDMR Shareholding
8th Dec 20252:00 pmRNSDirector/PDMR Shareholding
5th Dec 202512:16 pmRNSDirector/PDMR Shareholding
5th Dec 202512:15 pmRNSDirector/PDMR Shareholding
28th Nov 20252:40 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSFull Year Results
24th Nov 202512:30 pmRNSNotice of Final Results
10th Nov 20252:00 pmRNSDirector/PDMR Shareholding
31st Oct 202510:31 amRNSTotal Voting Rights
23rd Oct 20257:00 amRNSDirectorate Change
13th Oct 20252:27 pmRNSDirector/PDMR Shareholding
1st Oct 202510:07 amRNSBlock listing Interim Review
30th Sep 20251:58 pmRNSTotal Voting Rights
25th Sep 20257:00 amRNSPre-Close Trading Update
23rd Sep 202512:29 pmRNSNotice of Pre-Close Trading Statement
15th Sep 202512:00 pmRNSDirector/PDMR Shareholding
29th Aug 20252:00 pmRNSTotal Voting Rights
18th Aug 20251:59 pmRNSDirector/PDMR Shareholding
31st Jul 202511:18 amRNSTotal Voting Rights
25th Jul 20257:00 amRNSThird Quarter Trading Update
22nd Jul 202510:15 amRNSNotice of Third Quarter Trading Update
21st Jul 20252:30 pmRNSDirector/PDMR Shareholding
15th Jul 202512:38 pmRNSListing Application
30th Jun 20253:00 pmRNSTotal Voting Rights
27th Jun 202512:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.